Clinical trial

Bioidentical 'Natural' Hormone Evaluation in Early Menopause

NCT00302731 · Jeanne Drisko, MD, CNS, FACN, Other · Terminated

Key facts

NCT number NCT00302731
Title Bioidentical 'Natural' Hormone Evaluation in Early Menopause
Official title Prospective Double Blind Evaluation of Bioidentical Hormones
Lead sponsor Jeanne Drisko, MD, CNS, FACN, Other
Collaborators Private Foundation through KU Endowment University of Kansas
Status Terminated
Phase Phase 2
Study type Interventional
Conditions Menopause
Intervention type Drug
Interventions Estradiol, estriol, progesterone, estradiol, equine estrogens m-progesteroneacetate
Enrollment 21
Start date Feb 1, 2006
Primary completion Jan 1, 2014
Completion Sep 1, 2014
First posted Mar 14, 2006
Last update posted Jul 6, 2018
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies